NDC 51407-112 – Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC51407-112

Product details

Brand name
Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
EMTRICITABINE and TENOFOVIR Disoproxil Fumarate
Labeler
Golden State Medical Supply, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA091055
Marketed since
January 13, 2021
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
51407-112-3030 TABLET in 1 BOTTLE, PLASTIC (51407-112-30)Apr 9, 2021

Other Emtricitabine and tenofovir disoproxil fumarate products